Structures by: Siwek A.
Total: 4
6-acetyl-4,7-dimethyl-5-[3-(morpholin-4-yl)propoxycoumarin
C20H25O5N
Med. Chem. Commun. (2017)
a=17.1277(16)Å b=9.9821(9)Å c=10.6929(9)Å
α=90° β=96.349(2)° γ=90°
4,7-dimethyl-5-{3-[4-(2-fluorophenyl)piperazin-1-yl]propoxy}coumarin
C24H27O3N2F
Med. Chem. Commun. (2017)
a=7.7995(6)Å b=9.8117(8)Å c=14.8527(12)Å
α=78.6250(19)° β=82.4050(18)° γ=69.9762(18)°
4-Allyl-3-(pyrazin-2-yl)-Δ^2^-1H-1,2,4-triazole-5(4H)-thione
C9H9N5S
Acta Crystallographica Section E (2006) 62, 1 o128-o129
a=9.736(2)Å b=14.750(2)Å c=7.913(2)Å
α=90.00° β=112.57(3)° γ=90.00°
4-Methyl-N-(4-oxo-2-thioxoimidazolidin-3-yl)-1,2,3-thiadiazole-5-carboxamide
C7H7N5O2S2
Acta Crystallographica Section E (2006) 62, 3 o864-o865
a=7.528(2)Å b=7.2390(10)Å c=19.843(4)Å
α=90.00° β=91.74(3)° γ=90.00°